FDA Inspection 606585 — Oklahoma Blood Institute Northwest
The FDA completed an inspection of Oklahoma Blood Institute Northwest on August 13, 2009 in Enid, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 13, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Enid, OK (United States)